Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

63results about How to "Eliminate lesions" patented technology

Excisional biopsy devices and methods

InactiveUS6863676B2Efficiently and safely exciseMinimize complicationCannulasSurgical needlesUltrasonic sensorTissue Collection
An excisional biopsy system includes a tubular member that has a proximal end and a distal end in which one or more windows are defined. A first removable probe has a proximal portion that includes a cutting tool extender and a distal portion that includes a cutting tool. The first removable probe may be configured to fit at least partially within the tubular member to enable the cutting tool to selectively bow out of and to retract within one of the windows when the cutting tool extender is activated. A second removable probe has a proximal section that includes a tissue collection device extender and a distal section that includes a tissue collection device. The second removable probe may also be configured to fit at least partially within the tubular member to enable the tissue collection device to extend out of and to retract within one of the windows when the tissue collection device extender is activated. A third removable probe may also be provided. The third removable probe may also be configured to fit at least partially within the tubular member and may include an imaging device, such as an ultrasound transducer, mounted therein. By selectively activating the cutting tool and the tissue collection device while rotating the excisional device, a tissue specimen may be cut from the surrounding tissue and collected for later analysis.
Owner:ENCAPSULE MEDICAL

Excisional biopsy devices and methods

An excisional biopsy system includes a tubular member that has a proximal end and a distal end in which one or more windows are defined. A first removable probe has a proximal portion that includes a cutting tool extender and a distal portion that includes a cutting tool. The first removable probe may be configured to fit at least partially within the tubular member to enable the cutting tool to selectively bow out of and to retract within one of the windows when the cutting tool extender is activated. A second removable probe has a proximal section that includes a tissue collection device extender and a distal section that includes a tissue collection device. The second removable probe may also be configured to fit at least partially within the tubular member to enable the tissue collection device to extend out of and to retract within one of the windows when the tissue collection device extender is activated. A third removable probe may also be provided. The third removable probe may also be configured to fit at least partially within the tubular member and may include an imaging device, such as an ultrasound transducer, mounted therein. By selectively activating the cutting tool and the tissue collection device while rotating the excisional device, a tissue specimen may be cut from the surrounding tissue and collected for later analysis.
Owner:ENCAPSULE MEDICAL

Excisional biopsy devices and methods

An excisional biopsy device includes a tubular member having a window near a distal tip thereof; a cutting tool, a distal end of the cutting tool being attached near the distal tip of the tubular member, at least a distal portion of the cutting tool being configured to selectively bow out of the window and to retract within the window; and a tissue collection device externally attached at least to the tubular member, the tissue collection device collecting tissue excised by the cutting tool as the biopsy device is rotated and the cutting tool is bowed. An excision al biopsy method for soft tissue includes the steps of inserting a generally tubular member into the tissue, the tubular member including a cutting tool adapted to selectively bow away from the tubular member and an external tissue collection device near a distal tip of the tubular member; rotating the tubular member; selectively varying a degree of bowing of the cutting tool; collecting tissue severed by the cutting tool in the tissue collection device; and retracting the tubular member from the soft tissue. The tubular member may include an imaging transducer and the method may include the step of displaying information received from the transducer on a display device and the step of varying the degree of bowing of the cutting tool based upon the displayed information from the imaging transducer. Alternatively, the imaging transducer may be disposed within a removable transducer core adapted to fit within the tubular member.
Owner:ENCAPSULE MEDICAL

Vegetable drug compound preparation for treating urarthritis as well as preparation and application thereof

InactiveCN101757322AReduce accumulation of purine substancesLower blood uric acidSkeletal disorderPlant ingredientsArthritisAchyranthes
The invention relates to a vegetable drug compound preparation for treating urarthritis, which comprises the following components of radix angelicae pubescentis, large-leaved gentian, cassia twig, Korthalsella japonica, divaricate saposhnikovia root, processed radix aconiti lateralis, the root of bidentate achyranthes, fructus psoraleae, notopterygium root, poria cocos, angelica sinensis, ligusticum wallichii, rubefacient, the dried rhizome of rehmannia, the rhizome of oriental water plantain, the root of red-rooted salvia, astragalus mongholicus and liquorice. A preparation method of the vegetable drug compound preparation comprises the following steps of: according to the formula, adding 4-12 times of water, decocting for 1-3 h and filtering out medicine juice; adding 4-12 times of water, decocting for 0.5-2 h, filtering out medicine juice, merging the decocting solution in the two steps, standing, leaching supernatant, condensing the supernatant to have the proportion of 1.08-1.35, drying and adding medicine auxiliary materials to prepare the vegetable drug compound preparation. The vegetable drug compound preparation has the efficiencies of warming yang, easing pain, clearing heat, cooling blood, promoting blood circulation and stopping pain, can reduce blood uric acid, eliminate arthritis disease caused by uric acid crystal, prevent recrudescence and treat both principal and secondary aspect of disease. In addition, the vegetable drug compound preparation has the advantages of stable quality, convenient taking, high curative effect, no toxic and side effect and the like.
Owner:HONGKONG XIAOYUAN PHARMA GROUP

Externally used lotion for treating haemorrhoids

The invention discloses an externally used lotion for treating haemorrhoids and belongs to the technical field of traditional Chinese medicine. The externally used lotion for treating haemorrhoids is prepared from the following raw materials: 10 g of fructus aurantii, 10 g of scutellaria baicalensis, 10 g of rhizoma atractylodis, 10 g of pinellia ternata, 10 g of rhizoma, 10 g of peach seed, 10 g of alumen, 15g of rhizoma coptidis, 15 g of selfheal, 20 g of dandelion, 20 g of schizonepeta, 20 g of Chinese gall, 20 g of radix sophorae flavescentis, 20 g of golden cypress, 30 g of flos sophorae, 30 g of chrysanthemum, 30 g of honeysuckle, 6 g of rheum officinale and 6 g of liquorice. After the materials are mixed, the externally used lotion for treating haemorrhoids, disclosed by the invention, has synergistic medicine effect, has a direct efficacy on nidus and has effects of clearing heat, removing toxicity, activating blood, dispelling stasis, relaxing bowel, stopping bleeding and relieving pain. Through the adoption of the externally used lotion disclosed by the invention, nidus and symptoms of haemorrhoids can be eliminated, the blood circulation of anal venous plexus can be completely improved and enhanced, and a medical problem that the haemorrhoids are repeated and long lasting can be completely solved.
Owner:吴翠霞

Traditional Chinese medicine composition for treating cholecystitis

The invention discloses a traditional Chinese medicine composition for treating cholecystitis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 8-13 parts of scutellaria baicalensis, 13-20 parts of wolfberry fruit, 12-16 parts of scarlet swertia herb, 9-14 parts of loquat core, 10-15 parts of purslane, 8-12 parts of punctatelip woodbetony flower, 11-16 parts of gentianopsis barbata, 9-12 parts of ligusticum wallichii, 10-14 parts of tangut dragonhead, 12-16 parts of kalmegh, 12-15 parts of fleshfingered citron flower, 13-18 parts of gardenia jasminoides root, 12-18 parts of pericarpium citri reticulatae, 10-15 parts of celastrus orbiculatus and 13-16 parts of neat philippine violet herb. The traditional Chinese medicine composition has the excellent effects that the prescription composition is analyzed by the theory of the traditional Chinese medicine; a preparation method of reasonable and stable active components is researched according to the research results of physicochemical property and the pharmacologic action of the components contained in the medicines; and the traditional Chinese medicine composition has the efficacies of clearing heat, promoting diuresis, promoting blood circulation to remove blood stasis, dispersing stagnated liver qi to promote bile flow, and eliminating turbidity by purgation, is capable of fundamentally eliminating lesions and recovering the functions of internal organs, and is safe and effective.
Owner:王玉玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products